Continuous Improvement Versus Innovation: The Case for Sipuleucel-T

被引：3
|
作者：
Tombal, Bertrand [1 ]
机构：
[1] Catholic Univ Louvain, Serv Urol, Clin Univ St Luc, B-1200 Brussels, Belgium
来源：
EUROPEAN UROLOGY | 2012年 / 61卷 / 04期
关键词：
PROSTATE-CANCER; MITOXANTRONE; PREDNISONE; DOCETAXEL;
D O I：
10.1016/j.eururo.2011.11.033
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：648 / 649
页数：2
相关论文
共 50 条
  • [21] Beyond Sipuleucel-T: Immune Approaches to Treating Prostate Cancer
    Cheng, Michael L.
    Fong, Lawrence
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2014, 15 (01) : 115 - 126
  • [22] A Retrospective Observational Analysis of Overall Survival with Sipuleucel-T in Medicare Beneficiaries Treated for Advanced Prostate Cancer
    McKay, Rana R.
    Hafron, Jason M.
    Ferro, Christine
    Wilfehrt, Helen M.
    Fitch, Kate
    Flanders, Scott C.
    Fabrizio, Michael D.
    Schweizer, Michael T.
    ADVANCES IN THERAPY, 2020, 37 (12) : 4910 - 4929
  • [23] An overview of sipuleucel-T Autologous cellular immunotherapy for prostate cancer
    Wesley, Johnna D.
    Whitmore, James
    Trager, James
    Sheikh, Nadeem
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (04) : 520 - 527
  • [24] SIPULEUCEL-T (PROVENGE®) FOR CASTRATION-RESISTANT PROSTATE CANCER
    Sartor, Oliver
    BJU INTERNATIONAL, 2012, 110 (2B) : E105 - E105
  • [25] Sequencing therapy in advanced prostate cancer: focus on sipuleucel-T
    Quinn, David I.
    Vaishampayan, Ulka
    Higano, Celestia S.
    Lin, Daniel W.
    Shore, Neal D.
    Beer, Tomasz M.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (01) : 51 - 61
  • [26] Sipuleucel-T: A prostate cancer vaccine: "instructions for use" for urologists
    Ouzaid, I.
    Ravery, V.
    PROGRES EN UROLOGIE, 2011, 21 (09): : 595 - 598
  • [27] Sipuleucel-T: harbinger of a new age of therapeutics for prostate cancer
    Madan, Ravi A.
    Gulley, James L.
    EXPERT REVIEW OF VACCINES, 2011, 10 (02) : 141 - 150
  • [28] Sipuleucel-T for prostate cancer: the immunotherapy era has commenced
    Buonerba, Carlo
    Ferro, Matteo
    Di Lorenzo, Giuseppe
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (01) : 25 - 28
  • [29] Sipuleucel-T associated inflammatory cardiomyopathy: a case report and observations from a large pharmacovigilance database
    Moey, Melissa Y. Y.
    Jiwani, Rahim A.
    Takeda, Kotaro
    Prenshaw, Karyn
    Kreeger, R. Wayne
    Inzerillo, John
    Liles, Darla K.
    Marcu, C. Bogdan
    Lebrun-Vignes, Benedicte
    Morris, D. Lynn
    Ardhanari, Sivakumar
    Salem, Joe-Elie
    ESC HEART FAILURE, 2021, 8 (04): : 3360 - 3368
  • [30] Complete Biochemical (Prostate-specific Antigen) Response to Sipuleucel-T With Enzalutamide in Castration-resistant Prostate Cancer: A Case Report With Implications for Future Research
    Graff, Julie N.
    Drake, Charles G.
    Beer, Tomasz M.
    UROLOGY, 2013, 81 (02) : 381 - 383
12345